The role of innate immunity in the pathogenesis of acne

Dermatology

Volumn 206, Issue 2, 2003, Pages 96-105

  Koreck, A ^a   Pivarcsi, A ^b   Dobozy, A ^b   Kemeny L ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE

Author keywords

Acne; CD1d molecule; Toll like receptors

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 8; LEUKOTRIENE; LIPID; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ACNE; ADAPTATION; ARTICLE; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; KERATINIZATION; MICROFLORA; PATHOGENESIS; PRIORITY JOURNAL; SEBACEOUS GLAND; SEBUM SECRETION; SKIN DEFECT; SKIN INFLAMMATION;

ACNE VULGARIS; ANTIGENS, CD1; DROSOPHILA PROTEINS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; PROPIONIBACTERIUM ACNES; RECEPTORS, CELL SURFACE; SKIN; TOLL-LIKE RECEPTORS;

EID: 0037278372     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068476     Document Type: Article

References (98)

1. Norris JF, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988;118:651-659.
2. Cunliffe WJ: The sebaceous gland and acne - 40 years on. Dermatology 1998;196:9-15.
3. Aldana OL, Holland DB, Cunliffe WJ: Variation in pilosebaceous duct keratinocyte proliferation in acne patients. Dermatology 1998;196:98-99.
4. Gollnick HP, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A: Pathogenesis and pathogenesis related treatment of acne. J Dermatol 1991;18:489-499.
5. Knaggs HE, Holland DB, Morris C, Wood EJ, Cunliffe WJ: Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol 1994;102:89-92.
6. Cunliffe WJ, Holland DB, Clark SM, Stables GI: Comedogenesis: Some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000;142:1084-1091.
7. Hughes BR, Morris C, Cunliffe WJ, Leigh IM: Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol 1996;134:247-256.
8. Downing DT, Stewart ME, Wertz PW, Strauss JS: Essential fatty acids and acne. J Am Acad Dermatol 1986;14:221-225.
9. Kanaar P: Follicular-keratogenic properties of fatty acids in the external ear canal of the rabbit. Dermatologica 1971;142:14-22.
10. Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M: Sphingosyl-phosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 1998;110:253-258.
11. Toyoda M, Morohashi M: Pathogenesis of acne. Med Electron Microsc 2001;34:29-40.
12. Knaggs HE, Hughes BR, Morris C, Wood EJ, Holland DB, Cunliffe WJ: Immunohistochemical study of desmosomes in acne vulgaris. Br J Dermatol 1994;130:731-737.
13. Guy R, Kealey T: Modelling the infundibulum in acne. Dermatology 1998;196:32-37.
14. Piérard GE: Follicule to follicule heterogeneity of sebum excretion. Dermatologica 1986;173:61-65.
15. Thiboutot D, Gilliland K, Light J, Lookingbill D: Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 1999;135:1041-1045.
16. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S: Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995;105:209-214.
17. Leyden JJ, McGinley KJ, Vowels B: Propionibacterium acnes colonization in acne and non-acne. Dermatology 1998;196:55-58.
18. McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ: Regional variations in density of cutaneous propionibacteria: Correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1980;12:672-675.
19. Leeming JP, Holland KT, Cunliffe WJ: The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol 1988;118:203-208.
20. Burkhart CG, Burkhart CN, Lehmann PF: Acne: A review of immunologic and microbiologic factors. Postgrad Med J 1999;75:328-331.
21. Ashbee HR, Muir SR, Cunliffe WJ, Ingham E: IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Br J Dermatol 1997; 136:730-733.
22. Puhvel SM, Amirian D, Weintraub J, Reisner RM: Lymphocyte transformation in subjects with nodulocystic acne. Br J Dermatol 1977;97:205-211.
23. Kersey P, Sussman M, Dahl M: Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol 1980;103:651-655.
24. Jappe U, Ingham E, Henwood J, Holland KT: Propionibacterium acnes and inflammation in acne: P. acnes has T-cell mitogenic activity. Br J Dermatol 2002;146:202-209.
25. Vowels BR, Yang S, Leyden JJ: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect Immun 1995;63:3158-3165.
26. Scott DG, Cunliffe WJ, Gowland G: Activation of complement - A mechanism for the inflammation in acne. Br J Dermatol 1979; 101:315-320.
27. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, Urabe K, Furue M: Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J Dermatol Sci 2002;29:97-103.
28. Kemeny L, Ruzicka T: Lipid mediators. Hautarzt 1994;45:582-591.
29. Biochem Cell Biol 1998;30:173-178.
30. Zouboulis CC: Exploration of retinoid activity and the role of inflammation in acne: Issues affecting future directions for acne therapy. J Eur Acad Dermatol Venereol 2001; 15(suppl 3):63-67.
31. Alestas T, Fimmel S, Beutler C, Hakij N, Chen W, Muller-Decker K, Zouboulis CC: Presence of the arachidonic acid proinflammatory pathway in human sebocytes in vitro (abstract). J Invest Dermatol 2002;119:737.
32. Zouboulis CC: Is acne vulgaris a genuine inflammatory disease? Dermatology 2001;203: 277-279.
33. Feldhaus MJ, Weyrich AS, Zimmerman GA, McIntyre TM: Ceramide generation in situ alters leukocyte cytoskeletal organization and beta 2-integrin function and causes complete degranulation. J Biol Chem 2002;277:4285-4293.
34. Tokura Y, Wakita H, Seo N, Furukawa F, Nishimura K, Takigawa M: Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine. J Invest Dermatol Symp Proc 1999;4:184-189.
35. Yamamoto A, Takenouchi K, Ito M: Impaired water barrier function in acne vulgaris. Arch Dermatol Res 1995;287:214-218.
36. Seiffert K, Zouboulis CC, Seltmann H, Granstein RD: Expression of neuropeptide receptors by human sebocytes and stimulatory effect of their agonists on cytokine production (abstract). Horm Res 2002;53:102.
37. Böhm M, Zouboulis CC, Luger TA: Evidence for expression of mu-opoid receptors on human sebocytes which mediate paracrine and/or endocrine action of beta-endorphin (abstract). J Invest Dermatol 2002;119:278.
38. Bohm M, Schiller M, Stander S, Seltmann H, Li Z, Brzoska T, Metze D, Schioth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA: Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002;118:533-539.
39. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR: Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002;99:7148-7153.
40. Bohm M, Luger TA: The pilosebaceous unit is part of the skin immune system. Dermatology 1998;196:75-79.
41. Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML: The skin immune system (SIS): Distribution and immunophenotype of lymphocytes subpopulations in normal human skin. J Invest Dermatol 1987;88:569-573.
42. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-451.
43. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduc-tion. J Biol Chem 1999;274:10689-10692.
44. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
45. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-191.
46. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999;163:1-5.
47. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274: 17406-17409.
48. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan JP, Bloom BR, Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-736.
49. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253-258.
50. Medzhitov R, Janeway C: The Toll receptor family and microbial recognition. Trends Microbiol 2000;8:452-456.
51. Csato M, Bozoky B, Hunyadi J, Dobozy A: Candida albicans phagocytosis by separated human epidermal cells. Arch Dermatol Res 1986;279:136-139.
52. Csato M, Kenderessy AS, Dobozy A: Enhancement of Candida albicans killing activity of separated human epidermal cells by ultraviolet radiation. Br J Dermatol 1987;116:469-475.
53. Kirkpatrick CH, Rich RR, Bennett JE: Chronic mucotaneous candidiasis: Model-building in cellular immunity. Ann Intern Med 1971;74:955-978.
54. Csato M, Kenderessy AS, Dobozy A: Enhancement of Candida albicans killing activity of separated human epidermal cells by alpha-melanocyte stimulating hormone (letter). Br J Dermatol 1989;121:145-147.
55. Csato M, Kenderessy AS, Judak R, Dobozy A: Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells. Arch Dermatol Res 1990;282:348-350.
56. Szolnoky G, Bata-Csorgo Z, Kenderessy AS, Kiss M, Pivarcsi A, Novak Z, Nagy NK, Michel G, Ruzicka T, Marodi L, Dobozy A, Kemeny L: A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. J Invest Dermatol 2001;117: 205-213.
57. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V: Nitric oxide in human skin: Current status and future prospects. J Invest Dermatol 1998;110:1-7.
58. Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, Gudmundsson GH: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272:15258-15263.
59. Wiedow O, Harder J, Bartels J, Streit V, Christophers E: Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun 1998;248:904-909.
60. Harder J, Bartels J, Christophers E, Schroder JM: Isolation and characterization of human (beta)-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-5713.
61. Kenderessy AS, Kemeny L, Dobozy A: Nitric oxide is involved in the Candida albicans killing activity of keratinocytes (abstract). J Invest Dermatol 1996;107:452.
62. Harder J, Bartels J, Christophers E, Schroder JM: A peptide antibiotic from human skin (letter). Nature 1997;387:861.
63. Pivarcsi A, Réthi B, Szell M, Kenderessy AS, Beer ZS, Bata-Csorgo Z, Magocsi M, Rajnavölgyi É, Dobozy A, Kemeny L: Toll-like receptors 2 and 4 are expressed on human keratinocytes and mediate the killing of pathogens (abstract). J Invest Dermatol 2001;117:803.
64. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC: Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 2002;119:424-432.
65. Oeff M, Seltmann H, Hakiy N, Bognanoff B, Nastos A, Walters R, Bornstein SR, Zouboulis CC: Toll-like receptor 2 and 4-dependent regulation of inflammatory signaling in human sebocytes (abstract). J Invest Dermatol 2002;119:736.
66. Seltmann H, Zouboulis CC: Human sebocytes express CD14 molecules and their IL8 production induced by both CD14-dependent and independent pathway (abstract). J Invest Dermatol 2001;117:804.
67. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL: Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169:1535-1541.
68. Chronnell CM, Ghali LR, Ali RS, Quinn AG, Holland DB, Bull JJ, Cunliffe WJ, McKay IA, Philpott MP, Muller-Rover S: Human beta defensin-1 and -2 expression in human pilosebaceous units: Upregulation in acne vulgaris lesions. J Invest Dermatol 2001;117:1120-1125.
69. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Ruhl R, Chen W, Nau H, Orfanos CE: The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998;196:21-31.
70. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE: Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999;113:1011-1020.
71. Porcellli SA, Modlin RL: The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999;17:297-329.
72. Nieda M, Nicol A, Koezuka Y, Kikuchi A, Takahashi T, Nakamura H, Furukawa H, Yabe T, Ishikawa Y, Tadokoro K, Juji T: Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum Immunol 1999;60:10-19.
73. Joyce S: CD1d and natural T cells: How their properties jump-start the immune system. Cell Mol Life Sci 2001;58:442-469.
74. Exley M, Garcia J, Wilson SB, Spada F, Gerdes D, Tahir SM, Patton KT, Blumberg RS, Porcelli S, Chott A, Balk SP: CD1d structure and regulation of human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000;100:37-47.
75. Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS: Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology 1993;80:561-565.
76. Somnay-Wadgaonkar K, Nusrat A, Kim HS, Canchis WP, Balk SP, Colgan SP, Blumberg RS: Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol 1999;11:383-392.
77. Koreck A, Szony BJ, Farkas A, Bata Zs, Kemeny L, Drugarin D, Dobozy A: Fokozott CD1d kifejez dés psoriasisos b rben (increased CD1d expression in psoriatic skin). B rgyógy Vener Szle 2001;77:197-200.
78. Koreck A, Szell M, Pivarcsi A, Bata-Csorgo Z, Dobozy A, Kemeny L: Distinct isoforms of CD1d are expressed in keratinocytes in a proliferation-differentiation dependent manner (abstract). J Invest Dermatol 2002;119:748.
79. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG: NKT cells: Facts, functions and fallacies. Immunol Today 2000;21: 573-583.
80. Chen H, Paul WE: Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-2249.
81. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A: Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999;163:4647-4650.
82. Kumar H, Belperron A, Barthold SW, Bockenstedt LK: Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000; 165:4797-4801.
83. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS: CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002;8:588-593.
84. Actor JK, Olsen M, Hunter RLJ, Geng YJ: Dysregulated response to mycobacterial cord factor trehalose-6,6′-dimycolate in CD1D-/-mice. J Interferon Cytokine Res 2001;21:1089-1096.
85. Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, Grusby MJ, Tachado SD: CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999;283:225-229.
86. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ: Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol 2000;165:4076-4085.
87. Yanagihara Y, Shiozawa K, Takai M, Kyogoku M, Shiozawa S: Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin Exp Immunol 1999;118:131-136.
88. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998;391:177-181.
89. Hornemann S, Seltmann H, Kodelja V, Orfanos CE, Zouboulis CC: Interleukin 1α mRNA and protein are expressed in cultured human sebocytes at steady-state and their levels are barely influenced by lipopolysaccharides (abstract). J Invest Dermatol 1997;108:382.
90. Seltmann H, Hornemann S, Orfanos CE, Zouboulis CC: Linoleic acid induces accumulation of neutral lipids in undifferentiated human sebocytes and reduce spontaneous IL-8 secretion (abstract). Arch Dermatol Res 1999;291:181.
91. Seltmann H, Oeff M, Zouboulis CC: CD14 expression in human sebocytes and IL8 regulation by lipopolysaccharides, phorbol myristate acetate and linoleic acid (abstract). Arch Dermatol Res 2002;294:33.
92. Oeff M, Seltmann H, Hakiy N, Bogdanoff B, Nastos A, Walters R, Fimmel S, Bornstein SR, Zouboulis CC: Differential modulation of Toll-like receptor 2 and 4 expression in human sebocytes (abstract). J Invest Dermatol 2002;119:736.
93. Guy R, Kealey T: The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol 1998;110:410-415.
94. Walters CE, Ingham E, Eady EA, Cove JH, Kearney JN, Cunliffe WJ: In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms. Infect Immun 1995;63:1223-1228.
95. Kemeny L, Kenderessy AS, Ocsovszky I, Michel G, Ruzicka T, Dobozy A: Interleukin-8 induces HLA-DR expression on cultured human keratinocytes via specific receptors. Int Arch Allergy Immunol 1995;106:351-356.
96. Vega B, Jomard A, Michel S: Regulation of human monocyte Toll-like receptor 2 (TLR2) expression by adapalene (abstract). J Eur Acad Dermatol Venereol 2002;16:123-124
97. Kopp EB, Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999;11:13-18.
98. Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13-19.